Umut, Öykü
Gottschlich, Adrian
Endres, Stefan
Kobold, Sebastian http://orcid.org/0000-0002-5612-4673
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (641549, 955575, 641549, 955575)
Melanoma Research Alliance (409510, 409510)
H2020 European Research Council (756017, 756017)
Ludwig-Maximilians-Universität München
Article History
Received: 18 January 2021
Accepted: 6 March 2021
First Online: 8 April 2021
Conflict of interest
: Ö. Umut and A. Gottschlich declare that they have no competing interests. S. Kobold has received honoraria from Novartis and GSK. S. Kobold and S. Endres are inventors of several patents in the field of immuno-oncology. S. Kobold and S. Endres received research support from TCR2 Inc. and Arcus Bioscience for work unrelated to this manuscript.